Phase
Condition
Platelet Disorders
Leukemia
Lymphoproliferative Disorders
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥18 years
Confirmed diagnosis of CLL
Patient started treatment with monotherapy acalabrutinib (prescribed by physiciandecision no more than 4 weeks ago before screening)
Capability of providing written Informed Consent Form
Exclusion
Exclusion Criteria:
Patients not corresponded to inclusion criteria
Pregnancy
Lactation
Patients included in open-label trials
Previous Bruton tyrosine kinase inhibitors (BTKI) treatment
Study Design
Connect with a study center
Research Site
Ufa, Bashkortostan Republic 450054
Russian FederationSite Not Available
Research Site
Kaliningrad, Kaliningrad Region
Russian FederationSite Not Available
Research Site
Khabarovsk, Khabarovsk Region 680009
Russian FederationSite Not Available
Research Site
Syktyvkar, Komi Republic
Russian FederationSite Not Available
Research Site
Krasnoyarsk, Krasnoyarsk Region 660022
Russian FederationSite Not Available
Research Site
Saint Petersburg, Leningrad Region 198205
Russian FederationSite Not Available
Research Site
Moscow, Moscow Region 129110
Russian FederationSite Not Available
Research Site
Nizhny Novgorod, Nizhny Novgorod Region
Russian FederationSite Not Available
Research Site
Novosibirsk, Novosibirsk Region 630091
Russian FederationSite Not Available
Research Site
Yakutsk, Sakha Republic 677008
Russian FederationSite Not Available
Research Site
Saratov, Saratov Region 410028
Russian FederationSite Not Available
Research Site
Irkutsk,
Russian FederationSite Not Available
Research Site
Kalinigrad,
Russian FederationSite Not Available
Central city clinical hospital
Kaliningrad,
Russian FederationSite Not Available
Research Site
Nizhniy Novgorod, 603126
Russian FederationSite Not Available
Research Site
Tomsk, 634063
Russian FederationSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.